Inhibition of catalase and epoxide hydrolase by the renal cystogen 2-amino-4,5-diphenylthiazole and its metabolites.
Subchronic feeding of 2-amino-4,5-diphenylthiazole (DPT) to rats results in the development of renal cysts and has been used as a model system to study polycystic kidney disease. Because previous studies revealed changes in renal enzymes following DPT administration, a possible direct effect of DPT and its phenolic metabolites on catalase and a related enzyme, epoxide hydrolase, was examined. Experiments with three in vitro systems (suspensions of rabbit renal tubules, rat kidney homogenates, and commercially obtained bovine liver catalase) revealed direct inhibition of catalase activity by the diphenolic metabolite (diOH- DPT: 2-amino-4,5di(4'-hydroxyphenyl)-thiazole), the known renal cystogen nordihydroquaiaretic acid (NDGA) 2-amino-4(4'-hydroxyphenyl),5-phenyl-thiazole (4OH-DPT), and the known catalase inhibitor 3-amino-1,2,4-triazole; DPT did not inhibit catalase activity. Following oral administration to rats of the DPT congeners, 4OH-DPT caused the greatest decrease in both renal catalase and cytosolic epoxide hydrolase activities and the shortest time to onset of cystic lesions. In vitro, mouse liver cytosolic epoxide hydrolase activity was substantially inhibited by 4OH-DPT and dioH-DPT, and NDGA, but not by 2-amino-4-phenyl,5-(4'-hydroxyphenyl)-thiazole (5OH-DPT) or DPT itself. Microsomal epoxide hydrolase (mEH) activity was inhibited by 4OH-DPT, unaffected by DPT or dioH-DPT, and stimulated 2-fold by 5OH-DPT. Finally, mEH activity was substantially higher in samples of normal human kidney than in samples of kidney derived from a patient with autosomal recessive polycystic kidney disease; no differences were observed in cEH activity in these samples. Although the role of altered catalase and epoxide hydrolase activities in cystogenesis is unknown, DPT-induced cyst formation is associated with loss of these enzyme activities in kidney tissue. To our knowledge, this is the first report of an in vivo diminution of cytosolic epoxide hydrolase activity by xenobiotics.
Hjelle
J T
JT
Department of Basic Sciences, University of Illinois College of Medicine, Peoria 61656.
Guenthner
T M
TM
Bell
K
K
Whalen
R
R
Flouret
G
G
Carone
F A
FA
D015126:8,11,14-Eicosatrienoic Acid / Q000378:metabolism; D000818:Animals; D002374:Catalase / Q000037:antagonists & inhibitors*; D004851:Epoxide Hydrolases / Q000037:antagonists & inhibitors*; D007668:Kidney / Q000201:enzymology; D052177:Kidney Diseases, Cystic / Q000139:chemically induced*; D009637:Masoprocol / Q000494:pharmacology; D051381:Rats; D013844:Thiazoles / Q000378:metabolism / Q000633:toxicity*
D013844:Thiazoles; C002886:Bax 439; D009637:Masoprocol; D002374:Catalase; D004851:Epoxide Hydrolases; D015126:8,11,14-Eicosatrienoic Acid